← Open Payments lookup

SHAHBAZ KHAN: Open Payments

NPI 1619048295 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,343 in 125 payments from 15 companies in 2025. Trend: 2023 $2,986 · 2024 $3,314 · 2025 $4,343

Food & beverage: $4,243Education: $100
CompanyPaymentsAmount
Alkermes, Inc.17$647
E.R. Squibb & Sons, L.L.C.14$613
Axsome Therapeutics, Inc.13$483
ABBVIE INC.19$434
Teva Pharmaceuticals USA, Inc.7$400
Otsuka America Pharmaceutical, Inc.11$379
Vanda Pharmaceuticals Inc.11$375
Neurocrine BioSciences, Inc.11$371
Janssen Pharmaceuticals, Inc4$198
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$170

Products named: COBENFY, Auvelity, REXULTI, VRAYLAR, ARISTADA, FANAPT, INGREZZA, LYBALVI.

Industry payments across CA — which companies pay providers there.